Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03021759 · ClinicalTrials.gov registry record · NA
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 4,774
- Enrollment target
NCT03021759: Completed NA study, sponsored by University of Pennsylvania.
NCT03021759 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 4,774 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (240% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03021759, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,774 participants
- Enrollment target
Study Summary
In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
Primary Outcome
Percentage of patients eligible for a statin that have been prescribed a statin
Interventions
- BEHAVIORAL Active choice
- BEHAVIORAL Social comparison feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,774 participants |
| Start Date | 2017-02-21 |
| Est. Completion | 2017-04-21 |
| Phase | NA |
What the finished NCT03021759 record still lists
NCT03021759 is an interventional study that assigns participants to a tested intervention. Its 4,774 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (240% higher).
The record links to 0 conditions, and to 2 interventions - of which Active choice is the first listed.
NCT03021759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03021759 about?
NCT03021759 is a clinical study titled "Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence". In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
What is the current status of trial NCT03021759?
This trial is currently completed. It is a NA study. The enrollment target is 4,774 participants. The study started on 2017-02-21. Estimated completion is 2017-04-21.
What interventions are being tested in trial NCT03021759?
The interventions under investigation include: Active choice (BEHAVIORAL), Social comparison feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT03021759?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03021759's enrollment target sits among peer trials
4,774 28th of 2000 higher than 1,973 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI